[Survival following liver transplant due to imatinib-induced acute liver failure: a case study]

Farm Hosp. 2012 Jan-Feb;36(1):50-1. doi: 10.1016/j.farma.2010.12.004. Epub 2011 Apr 22.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Chemical and Drug Induced Liver Injury / etiology*
  • Contraceptives, Oral, Hormonal / adverse effects
  • Contraceptives, Oral, Hormonal / pharmacokinetics
  • Cytochrome P-450 CYP3A / metabolism
  • Drug Interactions
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Liver Failure / chemically induced
  • Liver Failure / surgery*
  • Liver Transplantation*
  • Piperazines / adverse effects*
  • Piperazines / pharmacokinetics
  • Piperazines / therapeutic use
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / pharmacokinetics
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Contraceptives, Oral, Hormonal
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human